Biotechnology

128 articles in this category (Page 6 of 6)

Stock Weather AIBiotechnologyClinical Trials

Negative free cash flow persists, but $799M cash runway and imminent Phase 2b obesity data create high-impact catalyst for stock upside.

Nov 18, 2025GPCR

Stock Weather AIBiotechnologyClinical Trials

Strong free cash flow and record-breaking Phase 3 trial success for Ziihera drive near-term upside potential.

Nov 18, 2025JAZZ

Stock Weather AIBiotechnologyClinical Trials

Negative free cash flow contrasts with imminent Phase II trial data readout for MCS-8, creating near-term catalyst-driven upside potential.

Nov 18, 2025MENS

Stock Weather AIBiotechnologyClinical Trials

Negative free cash flow contrasts with strong clinical trial results and FDA engagement plans, fueling near-term upside potential.

Nov 18, 2025NUVL

Stock Weather AIBiotechnologyEarnings

Strong free cash flow and low forward P/E meet upcoming earnings catalyst, driving near-term upside potential.

Nov 17, 2025JAZZ

Stock Weather AIBiotechnologyClinical Trials

Strong clinical data catalysts combined with negative free cash flow signal near-term upside driven by sentiment, not fundamentals.

Nov 17, 2025NUVL

Stock Weather AIBiotechnologyClinical-Stage Pharma

Strong cash runway and rising R&D spend align with upcoming TERN-701 data catalyst, driving near-term upside potential.

Nov 17, 2025TERN

Stock Weather AIBiotechnologyClinical Trials

Negative free cash flow offset by strong cash runway and imminent regulatory filings for Apitegromab, driving near-term upside potential.

Nov 14, 2025SRRK